Abstract
Extrudates consisting of various ratios of tripalmitin and polyethylene glycol as matrix materials were produced below their melting temperatures. Tailor-made dissolution profiles for the model drug theophylline anhydrate were obtained by varying the matrix composition. The hydrophilic polymer polyethylene glycol increases the dissolution rate of the drug from the extruded matrix by its dissolution and hence formation of an interconnected pore network alleviating the release of the drug. Even though lipid-based dosage forms often suffer from polymorphic transitions during manufacturing, affecting the dissolution profiles and stability, these extrudates were found to exhibit stable solid-state behaviour. No polymorphic transformations were evident after extrusion. Stability testing was performed by open storage experiments over one year in accelerated conditions (40 °C/75 %RH). Each formulation remained in its stable conformation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
